Prot# AEG35156-204: A Phase 1-2, Multicenter, Open-Label Study of the X-Linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas

Project: Research project

Project Details

StatusFinished
Effective start/end date9/15/10 → 9/15/13

Funding

  • Aegera Therapeutics Inc. (AEG35156-204)